相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
Yoshinori Takeda et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients
Renjie Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
A transcriptomic signature that predicts cancer recurrence after hepatectomy in patients with colorectal liver metastases
Yuma Wada et al.
EUROPEAN JOURNAL OF CANCER (2022)
Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment
Florian E. Buisman et al.
EUROPEAN JOURNAL OF CANCER (2022)
External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
Karen Bolhuis et al.
CANCERS (2022)
The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin
L. Vigano et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Colorectal liver metastasis: molecular mechanism and interventional therapy
Hui Zhou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled Trial
Yukihide Kanemitsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Centralized repeated resectability assessment of patients with colorectalliver metastases during first-line treatment: prospective study
H. Isoniemi et al.
BRITISH JOURNAL OF SURGERY (2021)
Impact of primary tumor location on patterns of recurrence and survival of patients undergoing resection of liver metastases from colon cancer
Nadia Russolillo et al.
HPB (2020)
Primary tumor location and the prognosis of patients after local treatment of colorectal liver metastases: a systematic review and meta-analysis
Florian E. Buisman et al.
HPB (2020)
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial
Chiara Cremolini et al.
LANCET ONCOLOGY (2020)
Comprehensive Evaluation of Relapse Risk (CERR) Score for Colorectal Liver Metastases: Development and Validation
Yijiao Chen et al.
ONCOLOGIST (2020)
A Novel Machine-Learning Approach to Predict Recurrence After Resection of Colorectal Liver Metastases
Anghela Z. Paredes et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan
Shin Kobayashi et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: A systematic review
Karen Bolhuis et al.
EUROPEAN JOURNAL OF CANCER (2020)
Repeat hepatectomy with systemic chemotherapy might improve survival of recurrent liver metastasis from colorectal cancera retrospective observational study
Hiroshi Matsuoka et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
Francois-Clement Bidard et al.
CELLS (2019)
Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases
Hauke Lang et al.
ANNALS OF SURGERY (2019)
RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases
Kristoffer W. Brudvik et al.
ANNALS OF SURGERY (2019)
Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes
Richard D. Riley et al.
STATISTICS IN MEDICINE (2019)
RAS Mutation is Associated with Unsalvageable Recurrence Following Hepatectomy for Colorectal Cancer Liver Metastases
Masayuki Okuno et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Biomarkers in colorectal liver metastases
S. Yamashita et al.
BRITISH JOURNAL OF SURGERY (2018)
Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases
G. A. Margonis et al.
BRITISH JOURNAL OF SURGERY (2018)
Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?
Camille L. Stewart et al.
CURRENT PROBLEMS IN SURGERY (2018)
Outcomes after repeat hepatic resection for recurrent metastatic colorectal cancer: A population-based study
Sulaiman Nanji et al.
AMERICAN JOURNAL OF SURGERY (2017)
Activating KRAS mutation is prognostic only among patients who receive preoperative chemotherapy before resection of colorectal liver metastases
Georgios Antonios Margonis et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors?
Katsunori Imai et al.
ONCOLOGIST (2016)
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
Karel G. M. Moons et al.
ANNALS OF INTERNAL MEDICINE (2015)
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection
Jean M. Butte et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
BRAF and RAS mutations as prognostic factors in metastatic colorectal cancer patients undergoing liver resection
M. Schirripa et al.
BRITISH JOURNAL OF CANCER (2015)
Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients
Luca Vigano et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Repeat liver resection for recurrent colorectal metastases: a single-centre, 13-year experience
Narendra Battula et al.
HPB (2014)
Margin Status Remains an Important Determinant of Survival After Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy
Andreas Andreou et al.
ANNALS OF SURGERY (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
Bernard Nordlinger et al.
LANCET ONCOLOGY (2013)
Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies
Valentin Rousson et al.
BMC MEDICAL INFORMATICS AND DECISION MAKING (2011)
A standard definition of major hepatectomy: resection of four or more liver segments
Srinevas K. Reddy et al.
HPB (2011)
Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases
L. J. M. Mekenkamp et al.
BRITISH JOURNAL OF CANCER (2010)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Outcome after Resection of Hepatic and Pulmonary Metastases of Colorectal Cancer
Hannes Neeff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2009)
Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis An International Multi-Institutional Analysis of 1669 Patients
Mechteld C. de Jong et al.
ANNALS OF SURGERY (2009)
Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis
H. Z. Malik et al.
EJSO (2007)
Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma
SA Shah et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2006)
分享论文
